Bronchiectasis and NTM 360 Published Manuscripts

Aksamit A, Lapinel NC, Choate, C, et. al. Association between bronchiectasis exacerbations and longitudinal changes in FEV1 in patients from the US bronchiectasis and NTM research registry. Respir Med. 2024 July, 228:107660. DOI: https://doi.org/10.1016/j.rmed.2024.107660

McShane PJ, Brunton, AE, Choate, R, et.al. Impact of Tobacco Smoking in Bronchiectasis: Data from the U.S. Bronchiectasis and Nontuberculous Mycobacteria Research Registry. Am J Respir Crit Care Med. 2024 July: 1;210(1):128-130. https://doi.org/10.1164/rccm.202402-0466RL

Lapinel NC, Choate, C, Aksamit A, et. al. Characteristics of exacerbators in the US Bronchiectasis and NTM Research Registry: a cross-sectional study. ERJ Open Res. June 2024, 00185-2024. DOI: https://doi.org/10.1183/23120541.00185-2024/p>

Aksamit TR, Locantore N, Addrizzo-Harris D, et al. Five-Year Outcomes Among U.S. Bronchiectasis and Nontuberculous Mycobacterial Registry Patients. Am J Respir Crit Care Med. Epub 2024 Apr 26; DOI: 10.1164/rccm.202307-1165OC.

Basavaraj A, Brunton AE, Choate R, et.al. Nebulized hypertonic saline and positive expiratory pressure device use in patients with bronchiectasis: Analysis from the United States Bronchiectasis and NTM Research Registry. Respir Res. Epub 24 April 2024. DOI: https://doi.org/10.1016/j.resmer.2024.101107.

Basavaraj A, Choate R, Becker C, et.al. Severity of bronchiectasis predicts use of and adherence to high frequency chest wall oscillation therapy - Analysis from the United States Bronchiectasis and NTM Research Registry. Respir Med. 2024 Mar; 223:107555. DOI: https://doi.org/10.1016/j.rmed.2024.107555

Karamooz E, Brixey A, Rydzak C et.al. Prevalence of pulmonary artery dilation in non-cystic fibrosis bronchiectasis: A CT analysis from a cohort of the US Bronchiectasis and Nontuberculous Mycobacteria Research Registry. J Thorac Dis. Epub 27 Feb 2024. DOI: https://doi.org/10.21037/jtd-23-1316.

Drysdale M, Choate R, Brunton AE, et al. Nontuberculous mycobacterial (NTM) infections in bronchiectasis patients: A retrospective US registry cohort study. Pulm Pharmacol Ther. 2023 Dec:83:102260. https://doi.org/10.1016/j.pupt.2023.102260. Epub 2023 Sep 21.

McShane PJ, Choate R, Johnson M, et al. Bronchiectasis and NTM Research Registry Investigators. Racial and ethnic differences in patients enrolled in the national bronchiectasis and nontuberculous mycobacteria research registry. Respir Med. 2023 Apr; 209:107167. DOI: https://doi.org/10.1016/j.rmed.2023.107167

Ku JH, Henkle E, Aksamit TR, et al. Treatment of Nontuberculous Mycobacterial (NTM) Pulmonary Infection in the US Bronchiectasis and NTM Registry: Treatment Patterns, Adverse Events, and Adherence to American Thoracic Society/Infectious Disease Society of America Treatment Guidelines. Clin Infect Dis. 2023 Jan 13;76(2):338-341. DOI: https://doi.org/10.1093/cid/ciac788

Henkle E, Brunton AE, Aksamit TR, Winthrop KL. Isolation of Pseudomonas aeruginosa after nontuberculous mycobacteria. IJTLD. 2022; 26(5): 460-462. DOI: https://doi.org/10.5588/ijtld.21.0572

Metersky ML, Choate R, Aksamit TR, Conrad D, Lapinel N, Maselli D, McShane PJ. Stenotrophomonas maltophilia in patients with bronchiectasis: An analysis of the US bronchiectasis and NTM Research Registry. Respir Med. 2022; 193: 106746. DOI: https://doi.org/10.1016/j.rmed.2022.106746

McShane PJ, Philley JV, Prieto DA, Aksamit TR. Global attitudes of health care providers about aerosolized airway clearance therapy in bronchiectasis patients during the coronavirus disease 2019 pandemic. Chronic Obstr Pulm Dis. 2021; 8(3): 319-325. doi: http://doi.org/10.15326/jcopdf.2021.0214

Metersky ML, Choate R; Bronchiectasis and NTM Research Registry Investigators. The Association of Long-term Macrolide Therapy and Nontuberculous Mycobacterial Culture Positivity in Patients With Bronchiectasis. Chest. 2021 Aug;160(2):466-469. Epub 2021 Feb 20. https://doi.org/10.1016/j.chest.2021.02.019

Pravosud V, Mannino DM, Prieto D, et al. Symptom burden and medication use among patients with nontuberculous mycobacterial lung disease. Chronic Obstr Pulm Dis. 2021; 8(2): 243-254. doi: http://doi.org/10.15326/jcopdf.2020.0184

Choate R, Aksamit TR, Manino D, et el. Pseudomonas aeruginosa associated with severity of non-cystic fibrosis bronchiectasis measured by the modified bronchiectasis severity score (BSI) and the FACED: The US bronchiectasis and NTM Research Registry (BRR) study. Respir Med. 2021; 177. Epub 2020 Dec 23. DOI: https://doi.org/10.1016/j.rmed.2020.106285

Basavaraj A, Choate R, Addrizzo-Harris D, et al. Airway Clearance Techniques in Bronchiectasis: Analysis From the United States Bronchiectasis and Non-TB Mycobacteria Research Registry. CHEST. 2020; 158(4): 1376-1384. DOI: https://doi.org/10.1016/j.chest.2020.06.050

Despotes KA, Choate R, Addrizzo-Harris D, et al. Nutrition and Markers of Disease Severity in Patients With Bronchiectasis. Chronic Obstr Pulm Dis. 2020; 7(4): 390-403. DOI: http://doi.org/10.15326/jcopdf.7.4.2020.0178

Eden E, Choate R, Barker A, et al. The clinical features of bronchiectasis associated with alpha-1 antitrypsin deficiency, common variable immunodeficiency and primary ciliary dyskinesia--results from the U.S. Bronchiectasis Research Registry. Chronic Obstr Pulm Dis. 2019; 6(2): 145-153. DOI: HTTP://DOI.ORG/10.15326/JCOPDF.6.2.2018.0156

Henkle E, Aksamit TR, Daley CL, et al. US Patient-Centered Research Priorities and Roadmap for Bronchiectasis. Chest. 2018; 154 (5), 1016-1023. DOI: HTTPS://DOI.ORG/10.1016/J.CHEST.2018.06.032

Metersky ML, Aksamit TR, Barker A, et al. The prevalence and significance of Staphylococcus aureus in patients with non–cystic fibrosis bronchiectasis. Ann Am Thorac Soc. 2018; 15:365–370. DOI: HTTPS://DOI.ORG/10.1513/ANNALSATS.201706-426OC

Henkle E, Chan B, Curtis JR, et al. Characteristics and Health-care Utilization History of Patients With Bronchiectasis in US Medicare Enrollees With Prescription Drug Plans, 2006 to 2014. Chest. 2018; 154(6): 1272-1273. DOI: https://doi.org/10.1016/j.chest.2018.07.014

Henkle E, Curtis JR, Chen L, et al. Comparative risks of chronic inhaled corticosteroids and macrolides for bronchiectasis. Eur Resp J. 2018; 54(1): 1801896. DOI: https://doi.org/10.1183/13993003.01896-2018

Henkle E, Aksamit TR, Barker AF, et al. Pharmacotherapy for Non-Cystic Fibrosis Bronchiectasis Results From an NTM Info & Research Patient Survey and the Bronchiectasis and NTM Research Registry. Chest. 2017; 152 (6), 1120-1127. DOI: HTTPS://DOI.ORG/10.1016/J.CHEST.2017.04.167

Ruffner MA, Aksamit TR, Thomashow B, et al. Frequency of untreated hypogammaglobulinemia in bronchiectasis. Ann Allergy Asthma Immunol. 2017; 119 (1), 83-85. DOI: HTTPS://DOI.ORG/10.1016/J.ANAI.2017.04.020

Aksamit TR, O’Donnell AE, Barker, A, et al. Adult Patients with Bronchiectasis A First Look at the US Bronchiectasis Research Registry. Chest. 2017; 151 (5), 982-992. DOI: HTTPS://DOI.ORG/10.1016/J.CHEST.2016.10.055

---